Genitourinary System Carcinoma — Trials

Genitourinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

4,919 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,501
Recruiting: 783
Ph III recruiting: 85
Growth YoY: +18.1%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (758)

clinicaltrialsPublishedShowing 201–250 of 564 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06228404	Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC	active not recruiting	Early Phase 1	18	Shanghai Changzheng HospitalOTHER	1	Jul 23, 2026	clinicaltrials
NCT06895811	Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC	active not recruiting	Phase 1	3	Shanghai Changzheng HospitalOTHER	1	Jul 23, 2026	clinicaltrials